Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.
Welzel T, Golhen K, Atkinson A, Gotta V, Ternant D, Kuemmerle-Deschner JB, Michler C, Koch G, van den Anker JN, Pfister M, Woerner A.
Welzel T, et al. Among authors: golhen k.
Pediatr Rheumatol Online J. 2024 Jan 2;22(1):5. doi: 10.1186/s12969-023-00930-8.
Pediatr Rheumatol Online J. 2024.
PMID: 38167019
Free PMC article.